Health Care·Health Care Equipment·$158.4B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.74 | N/A | -0.07% |
management commentary, guidance changes, and full analysis available with Pro.
| -0.07% |
Tone: Cautiously Optimistic
Management expressed satisfaction with the quarter's performance despite missing EPS expectations. They emphasized a commitment to innovation and growth.
We are pleased with our overall performance this quarter.
Our focus remains on innovation and expanding our product offerings.
Abbott Labs reported an EPS of $0.74, slightly missing expectations, but the stock rose 4.20% in reaction. This increase may reflect investor confidence in the company's long-term growth strategy and management's positive outlook despite the EPS miss. The lack of revenue data and guidance may leave some investors cautious moving forward.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
RESMED INC
Jan 22, 2018